Omnicell Current Ratio 2010-2023 | OMCL
Omnicell current ratio from 2010 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Omnicell Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2023-12-31 |
$0.93B |
$0.37B |
2.52 |
| 2023-09-30 |
$0.91B |
$0.37B |
2.47 |
| 2023-06-30 |
$0.88B |
$0.37B |
2.38 |
| 2023-03-31 |
$0.94B |
$0.45B |
2.06 |
| 2022-12-31 |
$0.88B |
$0.43B |
2.06 |
| 2022-09-30 |
$0.85B |
$0.38B |
2.25 |
| 2022-06-30 |
$0.79B |
$0.37B |
2.11 |
| 2022-03-31 |
$0.78B |
$0.95B |
0.82 |
| 2021-12-31 |
$0.78B |
$0.88B |
0.89 |
| 2021-09-30 |
$0.89B |
$0.34B |
2.62 |
| 2021-06-30 |
$0.98B |
$0.32B |
3.10 |
| 2021-03-31 |
$0.90B |
$0.29B |
3.09 |
| 2020-12-31 |
$0.83B |
$0.28B |
3.00 |
| 2020-09-30 |
$0.96B |
$0.23B |
4.12 |
| 2020-06-30 |
$0.47B |
$0.24B |
1.97 |
| 2020-03-31 |
$0.48B |
$0.25B |
1.93 |
| 2019-12-31 |
$0.48B |
$0.24B |
2.04 |
| 2019-09-30 |
$0.48B |
$0.23B |
2.09 |
| 2019-06-30 |
$0.43B |
$0.21B |
2.03 |
| 2019-03-31 |
$0.41B |
$0.21B |
1.96 |
| 2018-12-31 |
$0.40B |
$0.21B |
1.94 |
| 2018-09-30 |
$0.38B |
$0.21B |
1.78 |
| 2018-06-30 |
$0.36B |
$0.20B |
1.78 |
| 2018-03-31 |
$0.37B |
$0.22B |
1.68 |
| 2017-12-31 |
$0.35B |
$0.21B |
1.72 |
| 2017-09-30 |
$0.32B |
$0.21B |
1.53 |
| 2017-06-30 |
$0.30B |
$0.21B |
1.40 |
| 2017-03-31 |
$0.29B |
$0.20B |
1.49 |
| 2016-12-31 |
$0.32B |
$0.18B |
1.74 |
| 2016-09-30 |
$0.34B |
$0.20B |
1.70 |
| 2016-06-30 |
$0.31B |
$0.19B |
1.63 |
| 2016-03-31 |
$0.31B |
$0.20B |
1.55 |
| 2015-12-31 |
$0.26B |
$0.13B |
2.12 |
| 2015-09-30 |
$0.26B |
$0.12B |
2.12 |
| 2015-06-30 |
$0.29B |
$0.14B |
2.06 |
| 2015-03-31 |
$0.30B |
$0.11B |
2.73 |
| 2014-12-31 |
$0.28B |
$0.11B |
2.52 |
| 2014-09-30 |
$0.27B |
$0.11B |
2.41 |
| 2014-06-30 |
$0.28B |
$0.10B |
2.67 |
| 2014-03-31 |
$0.25B |
$0.09B |
2.72 |
| 2013-12-31 |
$0.23B |
$0.09B |
2.53 |
| 2013-09-30 |
$0.25B |
$0.10B |
2.50 |
| 2013-06-30 |
$0.21B |
$0.09B |
2.41 |
| 2013-03-31 |
$0.20B |
$0.09B |
2.30 |
| 2012-12-31 |
$0.18B |
$0.08B |
2.18 |
| 2012-09-30 |
$0.17B |
$0.08B |
2.12 |
| 2012-06-30 |
$0.16B |
$0.07B |
2.13 |
| 2012-03-31 |
$0.29B |
$0.06B |
4.68 |
| 2011-12-31 |
$0.28B |
$0.06B |
4.68 |
| 2011-09-30 |
$0.28B |
$0.06B |
4.60 |
| 2011-06-30 |
$0.27B |
$0.06B |
4.62 |
| 2011-03-31 |
$0.27B |
$0.06B |
4.58 |
| 2010-12-31 |
$0.27B |
$0.06B |
4.55 |
| 2010-09-30 |
$0.27B |
$0.06B |
4.61 |
| 2010-06-30 |
$0.26B |
$0.06B |
4.63 |
| 2010-03-31 |
$0.26B |
$0.06B |
4.38 |
| 2009-12-31 |
$0.25B |
$0.06B |
4.28 |
| 2009-09-30 |
$0.25B |
$0.06B |
4.02 |
| 2009-06-30 |
$0.24B |
$0.06B |
4.01 |
| 2009-03-31 |
$0.23B |
$0.06B |
4.11 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$1.294B |
$1.147B |
|
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
|
